|
58
|
247
|
7ty2A |
Crystal structure of setd2 bound to an indole-based inhibitor |
|
59
|
248
|
7ty3A |
Crystal structure of setd2 bound to an indole-based inhibitor |
|
96
|
288
|
7uyrA |
Crystal structure of tyk2 kinase domain in complex with compound 12 |
|
86
|
287
|
7uyvA |
Crystal structure of jak3 kinase domain in complex with compound 25 |
|
82
|
288
|
7uysA |
Crystal structure of tyk2 kinase domain in complex with compound 16 |
|
88
|
290
|
7uywA |
Crystal structure of jak2 kinase domain in complex with compound 30 |
|
84
|
288
|
7uytA |
Crystal structure of tyk2 kinase domain in complex with compound 25 |
|
85
|
289
|
7uyuA |
Crystal structure of tyk2 kinase domain in complex with compound 30 |
|
33
|
126
|
7ssbA |
Co-structure of pkg1 regulatory domain with compound 33 |
|
0
|
20
|
7urdB |
Human porcn in complex with lgk974 and wnt3a peptide |
|
154
|
453
|
7ureA |
Human porcn in complex with palmitoleoylated wnt3a peptide |
|
194
|
491
|
7urfA |
Human hhat h379c in complex with shh n-terminal peptide |
|
160
|
453
|
7urdA |
Human porcn in complex with lgk974 and wnt3a peptide |
|
20
|
107
|
7uraL |
Human porcn in complex with palmitoleoyl-coa |
|
21
|
107
|
7ureL |
Human porcn in complex with palmitoleoylated wnt3a peptide |
|
27
|
119
|
7urdH |
Human porcn in complex with lgk974 and wnt3a peptide |
|
92
|
291
|
7up7A |
Crystal structure of c-terminal domain of msk1 in complex with covalently bound with literature rsk2 inhibitor indazole cyanoacrylamide compound 26 (soak) |
|
14
|
117
|
7urfO |
Human hhat h379c in complex with shh n-terminal peptide |
|
155
|
453
|
7uraA |
Human porcn in complex with palmitoleoyl-coa |
|
146
|
453
|
7urcA |
Human porcn in complex with lgk974 |
|
18
|
111
|
7urfP |
Human hhat h379c in complex with shh n-terminal peptide |
|
24
|
119
|
7uraH |
Human porcn in complex with palmitoleoyl-coa |
|
1
|
20
|
7ureB |
Human porcn in complex with palmitoleoylated wnt3a peptide |
|
22
|
119
|
7ureH |
Human porcn in complex with palmitoleoylated wnt3a peptide |
|
17
|
107
|
7urdL |
Human porcn in complex with lgk974 and wnt3a peptide |
|
15
|
107
|
7urcL |
Human porcn in complex with lgk974 |
|
20
|
119
|
7urcH |
Human porcn in complex with lgk974 |
|
132
|
380
|
7rxvA |
Human methionine adenosyltransferase 2a bound to methylthioadenosine, malonate (mla) and mgf3 |
|
236
|
948
|
6xrnA |
Crystal structure of human pi3k-gamma in complex with compound 17 |
|
310
|
946
|
7jiuA |
Human pi3kdelta in complex with compound 2f |
|
90
|
270
|
7n5oA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
89
|
270
|
7n5rA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5yA |
Fragment-based drug design of a novel, covalent bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5xA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
75
|
295
|
7lvhA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand n-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
|
83
|
297
|
7lviA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand (2r)-2-amino-n-[3-methoxy-4- (1,3-oxazol-5-yl)phenyl]-4-methylpentanamide |
|
101
|
328
|
7l1xA |
Structure of human ck2 alpha kinase (catalytic subunit) with the inhibitor 108600. |
|
86
|
308
|
7k1iA |
Egfr kinase (l858r/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
94
|
308
|
7jxpA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-04-125-02 |
|
94
|
308
|
7jxqA |
Egfr kinase (t790m/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
88
|
308
|
7jxmA |
Egfr kinase (t790m/v948r) in complex with osimertinib and eai045 |
|
79
|
287
|
7jxhA |
Her2 in complex with jbj-08-178-01 |
|
86
|
308
|
7jxwA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-09-063 |
|
85
|
313
|
7jxlA |
Egfr kinase (t790m/v948r) in complex with az5104 |
|
89
|
307
|
7k1hA |
Egfr l858r/v948r in complex with osimertinib and allosteric inhibitor jbj-09-063 |
|
88
|
308
|
7jxkA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 and jbj-04-125-02 |
|
88
|
307
|
7jxiA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 |
|
68
|
289
|
7dxlA |
Fragment-based lead discovery of indazole-based compounds as axl kinase inhibitors |
|
117
|
347
|
6ln1A |
A natural inhibitor of dyrk1a for treatment of diabetes mellitus |
|
185
|
697
|
7rbqA |
Co-crystal structure of human prmt9 in complex with mt556 inhibitor |
